Click to open
Skip to content
EMAS Virtual Meeting
EMAS Virtual Meeting
  • Home login
  • Registration
  • Programme
  • Privacy Policy
  • Home login
  • Registration
  • Programme
  • Privacy Policy

Gilead Science

Gileads

Description

Platinum sponsor

Supported by Gilead Sciences Europe Ltd who provided funding. Gilead Sciences Europe Ltd. has had no input into the content of the materials and presentations used at this event..

Video

Documents

Click here

Gilead Sciences has pursued – and achieved – breakthroughs once thought impossible in medicine for more than three decades, with the goal of creating a healthier world for all people.

At Gilead, we have pioneered more than 25 medicines since our founding in 1987 and have an expanding portfolio of investigational compounds.

We have helped transform care for people living with HIV, developing the world’s

first HIV single tablet regimen to treat the disease and the first medicines to prevent infection with the HIV virus. Our scientists are continuing to pursue new kinds of treatment, such as long-acting antivirals, and the ultimate goal: a cure.

Building on our success in HIV, we applied the same tenacity to hepatitis C virus (HCV), delivering four curative treatments in less than four years. Today, more than 4 million people have been prescribed our HCV therapies.

Through our Kite operating company in Southern California, we are on a path to a potential cure for cancer with our cutting-edge cell therapy program.

Through research and development we’re creating possibilities that include a wide range of clinical studies evaluating compounds with the potential to become the next generation of life-changing medicines. We believe the impossible is not impossible. It simply hasn’t been achieved yet.

Get in touch

Virtual business card

Click here

Visit our website

Click here

Social Media

Facebook
Twitter
Linkedin

Open PDF in a lightbox popup
  • Privacy Policy
Privacy Policy
Go to Top
UMSA Library
N.TitleAction
1Document Sample

Click to Open

2Document Sample

Click to Open

3Document Sample

Click to Open

4Video Sample

Click to Open

5Video Sample

Click to Open

6Video Sample

Click to Open

1:1 meeting scheduling

Videos on Demand
Session NumberPresenterSessionPresentation titleAccess
S1-1Prof. Th. DagklisSession 1 - The contextsThe epidemiology of late parenthoodView Session
S1-2Dr. A. KapraraSession 1 - The contextsPathophysiology of infertility in advanced age malesView Session
S1-3Prof. N.P. PolyzosSession 1 - The contextsPathophysiology of infertility in advanced age femalesView Session
S1-4Prof. L. AthanasiadisSession 1 - The contextsPsychological aspects of late parenthoodsoon available
S2-1Prof. N. Garrido PuchaltSession 2 - The consequencesPregnancy complications due to advanced paternal ageView Session
S2-2Prof. Κ. BambangSession 2 - The consequencesPregnancy complications due to advanced maternal ageView Session
S2-3Prof. A. PinborgSession 2 - The consequencesLate parenthood: Short-term health of the offspringView Session
S2-4Prof. S.T. DavidgeSession 2 - The consequencesPregnancy complications and long term health of the offspringView Session
S3-1Prof. H. TournayeSession 3 - The treatmentsManagement of infertility in advanced age malesView Session
S3-2Prof. G. GriesingerSession 3 - The treatmentsManagement of infertility in advanced age femalesView Session
S4-1Dr. Ch. TsametisSession 4 - The casesAdvanced paternal ageView Session
S4-2Dr. J. Bosdou Session 4 - The casesAdvanced maternal ageView Session
S4-3Dr. V. Korvesi Session 4 - The casesPregnancy complicationsView Session
S4-4Prof. G. MitsiakosSession 4 - The casesLate parenthood: Offspring health, the caseView Session
CCProf. D.G. Goulis, Prof. E.M. KolibianakisConclusions and ClosingConclusions and ClosingView Session
ES-1Panelistas Sesión 1 - Coordinador: Juan Enrique BlümelSesión 1 - Impacto del Climaterio en la salud de la Mujer Debate en climaterio - grabación en vivo, junio 19View Session
ES-2Panelistas Sesión 2 - Coordinador: Antonio CanoSesión 2 - El arte del uso de hormonas en el climaterio Debate en climaterio - grabación en vivo, junio 19View Session
Eposter Library
Programme Day 2
View Fullscreen
Programme Day 1
View Fullscreen
Channel 1
Rate

Please give a rate

Comments to author

[contact-form-7 id=”2462″ title=”Comments to author”]

Rating

Please give a rate



Dr. Begoña Bermejo

 

Physician and medical doctor from the University of Cadiz. Medical oncologist at the Clinical University Hospital of Valencia and Biomedical Research institute INCLIVA
Associate Professor of Medicine School at University of Valencia

She develops her assistance and research work in the breast pathology unit. She has an extensive experience in clinical trials and research projects in the area of breast cancer.Member of the breast cancer research group at the Carlos III institute.Member of the board of GEICAM (Spanish Breast Cancer Research Group)

 

Dr. Enrique Santas Olmeda

 

Dr. Enrique Santas, MD, PhD,  is a cardiologist at the Hospital Clínico Universitario in Valencia (Spain). He is an active clinician and an emergent researcher, with a focus on heart failure and cardiac imaging. Currently, he is the director of the cardio-oncology program at his institution, dedicated to the cardiovascular health of patients undergoing cancer treatment as well as cancer survivors.

 

Virtual Business Card

If a HCP has a request for medical information regarding our Gilead products, they can contact us:

Via phone: +1-866-MEDI-GSI (1-866-633-4474), or

Submit an inquiry online at https://www.askgileadmedical.com/, via the webform under “Inquire”  

Join a meeting